Recruitment
PRESS RELEASE: clinical study for our lead product, pHyph, a vaginal tablet for topical treatment of bacterial vaginosis (BV), completes recruitment!
"Really fantastic feeling to have finalized enrolment of the 150 patients in our placebo-controlled study in bacterial vaginosis #Nefertiti - What an achievement by the Gedea Biotech AB…






